Member Info for MartyMcFlySr

This dip has proved a rdip in SPleal buying opportunity. NE Director buying, Investors Chronicle reiterating buy advice and Daily Telegraph moving to sell (grudgingly) citing the fact that this share burnt their fingers in 2017. Will reach £20 again and surpass it. CEO even said in update ot is better to under promise and as good as stating the current months are record breaking and well above broker expectations. I've bought more!

Year on year figures show EBITDA up 38%, EPS up 100%, operating profit up 55%, staff vacancy rate stable net debt is down over 50%.

Not a bad figure in there. My guesstimate of £20 seems undervalued.

Somebody please nudge the analysts, current ratings arent close to matching recent trading updates.

Buy buy buy buy buy buy buy!

Yes, still plenty of upside here. Results on Thursday will be positive as trading statement said. Analysts will need to upgrade their views significantly following that. I expect £20 will be reached and likely to top out there for now.

Added to Simon's Bargain shares 2021.
https://www.investorschronicle.co.uk/ideas/2021/02/04/bargain-shares-for-2021/

Hopefully will enjoy a boost as added to Simon's Bargain shares 2021.
https://www.investorschronicle.co.uk/ideas/2021/02/04/bargain-shares-for-2021/
Already going well....

Much better. Just took the market a while to react.

I do struggle to understand the lack of enthusiasm here. This stock should have broken the stratosphere. I guess the March half year results will have to spell it out more clearly to the market. Have now got 20k shares and plan to add more next week if this fails to lift off. There is no question there is huge value to be had here.

An even more positive update today than the full year results. Sales, EBITDA and staff numbers all up. That analyst upgrade is yet to come but this stock is screaming for it. We should be north of £16 and more with this announcement. GLA!

There seems to have been some unexplained positive activity in the share price today and a trading update is due. More good news ahead? Pets at Home already reporting strong results for last quarter.

These are crazy figures. Each practice, on average is valued at 20 million. Some of these are small referral practices or recent start ups e.g. Livingston. If this valuation adds value to Mars then CVS is looking good, 7 referral practices on last count.

I dont think this could be better. EBITDA increased in size and margin compared to this time last year. Above budget. We will have to have a re rating in the next few days. This should easily reach £14 and cover the lost ground from a few years ago. A new all time high? Maybe by January.

Last chance to buy ahead if interim results tomorrow morning. Expecting positive things. Am a big shareholder here. Pets at Home released yesterday with positive update and continued strong sales. GLA.

IVC is planning to float with valuation of £10bn. IVC is not 10x bigger than CVS. Could an upgrade be on the way? Interim report due on thurs so well worth buying ahead of update. Vets are flying, see Pets at Home.

https://www.google.com/amp/s/amp.ft.com/content/4a5bb92e-162b-404c-a156-2cfb5a305ddf